RxDoctor Payments Data

Robert Cadoff, MD

Urology · Soldotna, AKNPI 1821086927

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $485 of the $620 with a category attached, or 78.2%. 7 manufacturers reported payments, led by Olympus Corporation Of The Americas at 43.6% of the total. Reporting peaked in 2020 at $345 and has fallen 50.5% since, to $171 in 2025. That places this record below the midpoint for urology clinicians in AK, where the typical reported total is $2,491.

$620in general payments, 2019–2025

Across 19 payments — averaging $32.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Olympus Corporation Of The Americas$270
  • Boston Scientific$184
  • Neotract Inc.$75
  • Medtronic$39
  • AstraZeneca$25
  • Myriad Genetic Laboratories, Inc.$22
  • plus $5 from 1 others

What the payments were for

  • Travel & lodging$13522%
  • Food & beverage$48578%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$620 in reported general payments places this provider in the 25th percentile of 28 urology providers in Alaska.

See all urology providers in Alaska

Medicare billing

Part B allowed, 2024
$212,430
Medicare patients
743
Services billed
1,945

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron69$45,807
Tamsulosin Hcl782$16,262
Methenamine Hippurate183$11,313
Finasteride459$6,889
Testosterone27$4,466
Dutasteride91$3,453
Potassium Citrate ErPotassium Citrate13$1,961
Oxybutynin Chloride ErOxybutynin Chloride109$1,891
Tadalafil15$1,838
Silodosin22$911
Trospium Chloride19$362
Terazosin Hcl25$254
Oxybutynin Chloride53$212
Cephalexin37$147
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav12$78

Paid to pharmacies, not to this prescriber.

Other urology in Soldotna

See the full list for Alaska

Where these figures come from

Is this you, or does something look wrong? →